Thyrocare Technologies

₹498.95As of Sun 8 Nov 2026, 12:00 UTC

NSE:THYROCAREHealthcare

Country India

PE (Fwd) 45.29

TSR 10Y CAGR 10.95%

Div yield 1.87%

ROE —

Diagnostics & Research

Beta (5Y) 0.50

PE TTM 48.85

TSR TTM 8.52%

Mkt cap ₹76.82B

ROIC —

SE Grade™

Value

Quality

Moat

—

1Y Price

Reference

₹545

9.26%

(84.80%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

8.290

Revenue₹B

—

5.889

5.267

5.719

6.873

8.290

8.805

8.93%

20.61

Revenue growth%

—

(10.56)

8.59

20.19

20.61

6.21

14.39

—

54.00

Gross margin%

—

58.92

46.00

48.17

50.26

54.00

53.59

50.26

24.58

Operating margin%

—

34.14

15.61

16.04

19.67

24.58

24.00

19.67

Net margin%

—

29.91

12.24

12.37

13.31

19.67

19.11

13.31

48.85

P/E ratio (avg)x

—

35.58

51.33

42.77

47.13

41.99

47.33

42.77

39.09

EV/EBITx

—

31.17

40.28

33.00

31.90

33.60

37.69

33.00

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

100

10.21

EPS₹

—

11.08

4.06

4.45

5.74

10.21

10.54

(2.02%)

—

78.08

EPS growth%

—

(63.40)

9.66

28.98

78.08

3.23

19.32

—

Bookvalue per sh₹

—

FCF per share₹

—

9.33

Dividend per sh₹

—

5.00

6.00

7.00

9.33

9.98

16.88%

—

1.87

Div yield (avg)%

—

1.27

2.88

3.15

2.59

2.18

2.00

2.59

91.35

Payout ratio%

—

45.11

147.95

134.93

122.05

91.35

94.67

122.05

159.6

Shares (diluted)M

—

159.0

159.1

159.6

◌159.6

0.11%

(0.05)

Buyback yield%

—

(0.05)

(0.06)

(0.27)

(0.05)

◌—

(0.06)

—

D/E ratiox

—

79.65

Enterprise value₹B

—

62.66

33.11

30.26

43.13

68.47

79.65

2.24%

—

LT debt₹M

—

Peers (US$837.4M)

Cap (US$)

Syngene International…

1.760B

89.47x

Vijaya Diagnostic…

1.613B

74.47x

Metropolis Healthcare…

1.262B

52.76x

Maccura Biotechnology…

821.2M

—

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

72.78

44.04

Own earn%

—

Sh yield%

1.82

2.58

Owners

Insiders/Inst%

—

28.44

Short interest%

—

SBC / revenue%

2.55

Record

10Y

Profitable years

5/5

Revenue growth years

3/4

EPS growth years

3/4

Dividend streakyrs

Op margin range%

16–34

$1 testx

—

Incr. ROIC%

—

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹8.290B

8.93%

1.00×

Cost of revenue

₹3.814B

12.05%

1.12×

Operating expenses

₹2.439B

13.70%

1.19×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m